In recent years, several studies have investigated the potential role of Nrf2 protein, which plays critical roles in carcinogenesis, tumor progression and chemotherapy resistance (35, 42, 43), but not before B-ALL. The gene discussed is NFE2L2; the disease is neoplasm.